Sonoma Pharmaceuticals Inc (SNOA) Stock Price, Quote & News

Company Profile

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild t...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 800 759 9305

Website: sonomapharma.com

Address:

5445 Conestoga Court, Suite 150, Boulder, United States

StarlinePalaceTrades Mar. 31 at 4:32 PM

$SNOA Can make big moves on volume

0 · Reply

FshOn Mar. 24 at 2:32 PM

$SNOA wow, great news no volume. See ya

0 · Reply

Stock_Catcher Mar. 24 at 12:30 PM

$SNOA Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

1 · Reply

Love_To_Learn Mar. 23 at 11:39 AM

$SNOA u have an update pending btw

0 · Reply

noname10000 Mar. 18 at 12:35 PM

$SNOA news

0 · Reply

frontiere Mar. 17 at 8:36 PM

$SNOA Sonoma ref=$2.40 today - been months since I updated my prior thread here, holding long now from higher, as thought this was due bullish news earlier. They are near historical lows on Cash, must raise soon thus motivated to support stock price. SNOA will be at American Association of Dermwtology AAD in Denver March 27-31 — maybe some news then, too. But patient regardless.

1 · Reply

OfficialStocktwitsUser Feb. 27 at 3:20 AM

$SNOA RSI: 41.98, MACD: -0.1299 Vol: 0.19, MA20: 2.97, MA50: 3.30 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

PenkeInvesting Feb. 25 at 3:09 PM

Fundamental analysis of $SNOA (Sonoma Pharmaceuticals, Inc.) based on financial data and reported results. #SNOA #Sonoma

0 · Reply

BillionerOfKing Feb. 18 at 8:23 PM

$SNOA Current Stock Price: $2.84

0 · Reply

trader87 Feb. 11 at 3:42 PM

$SNOA fully loaded for the next spike, GL

2 · Reply

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

Mar 18, 2026, 8:30 AM EDT - 17 days ago

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

Feb 10, 2026, 4:10 PM EST - 7 weeks ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Jan 28, 2026, 4:15 PM EST - 2 months ago

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

Nov 13, 2025, 8:30 AM EST - 5 months ago

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Nov 6, 2025, 4:01 PM EST - 5 months ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

Nov 4, 2025, 8:56 AM EST - 5 months ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Oct 14, 2025, 8:30 AM EDT - 6 months ago

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

Oct 7, 2025, 8:30 AM EDT - 6 months ago

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

Sep 25, 2025, 4:01 PM EDT - 6 months ago

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Aug 26, 2025, 8:30 AM EDT - 7 months ago

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 13, 2025, 4:01 PM EDT - 8 months ago

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Aug 7, 2025, 4:15 PM EDT - 8 months ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Jun 17, 2025, 4:10 PM EDT - 10 months ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Apr 22, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Mar 10, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Feb 25, 2025, 4:01 PM EST - 1 year ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 5, 2025, 4:05 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Dec 5, 2024, 8:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Nov 21, 2024, 4:06 PM EST - 1 year ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 11, 2024, 4:20 PM EST - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Nov 7, 2024, 8:45 AM EST - 1 year ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Oct 31, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Oct 22, 2024, 8:35 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 21, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Aug 28, 2024, 6:10 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 26, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 21, 2024, 8:45 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Jul 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jun 17, 2024, 5:00 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

May 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Mar 28, 2024, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 27, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Feb 8, 2024, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Jan 23, 2024, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

NBY

Nov 13, 2023, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Oct 26, 2023, 9:10 AM EDT - 2 years ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Aug 15, 2023, 7:30 AM EDT - 2 years ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Jun 22, 2023, 7:30 AM EDT - 3 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Jun 9, 2023, 5:05 PM EDT - 3 years ago

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

StarlinePalaceTrades Mar. 31 at 4:32 PM

$SNOA Can make big moves on volume

0 · Reply

FshOn Mar. 24 at 2:32 PM

$SNOA wow, great news no volume. See ya

0 · Reply

Stock_Catcher Mar. 24 at 12:30 PM

$SNOA Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

1 · Reply

Love_To_Learn Mar. 23 at 11:39 AM

$SNOA u have an update pending btw

0 · Reply

noname10000 Mar. 18 at 12:35 PM

$SNOA news

0 · Reply

frontiere Mar. 17 at 8:36 PM

1 · Reply

OfficialStocktwitsUser Feb. 27 at 3:20 AM

0 · Reply

PenkeInvesting Feb. 25 at 3:09 PM

Fundamental analysis of $SNOA (Sonoma Pharmaceuticals, Inc.) based on financial data and reported results. #SNOA #Sonoma

0 · Reply

BillionerOfKing Feb. 18 at 8:23 PM

$SNOA Current Stock Price: $2.84

0 · Reply

trader87 Feb. 11 at 3:42 PM

$SNOA fully loaded for the next spike, GL

2 · Reply

trader87 Feb. 10 at 11:32 AM

$SNOA loading levels again- swing entry, pt 4.50

0 · Reply

Love_To_Learn Jan. 12 at 5:57 PM

$SNOA NEED TO INCREASE FLOAT BY 8.4 MILLION TYPE B SHARES OFF THE BOOKS! CHANGING UPDATE

1 · Reply

Love_To_Learn Jan. 12 at 3:22 PM

$SNOA NEED U *

1 · Reply

DelayDust Dec. 27 at 5:53 PM

$SNOA Capital flows appear selective and reward repeatability; pipeline visibility needs clearer corroboration — consistent delivery could invite longer‑term shareholders. From here, results — not promises — will decide direction.

0 · Reply

kshonstocks Dec. 9 at 5:13 PM

$SNOA thru 50 dma

0 · Reply

ItTakesItAll Dec. 9 at 3:18 PM

$SNOA Adding again, little by little, 3.10s-3.50s

0 · Reply

topstockalerts Dec. 1 at 10:55 PM

After Hours Top Gainers PT2 $ARTL $CMND $IVF $LAB.X $SNOA

0 · Reply

SPACEDAD Dec. 1 at 9:20 PM

$SNOA on watch for possible short squeeze

0 · Reply

newbulloh2 Nov. 26 at 4:39 PM

$SNOA tank tank tank!!!! Below 2 in due time baby

0 · Reply

TradeHawk Nov. 21 at 5:54 PM

$SNOA Sonoma Pharmaceuticals and partner MicroSafe Care have received Australian Therapeutic Goods Administration approval for its Nanocyn Advanced Disinfectant & Sanitizer. https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=520725&agid=%28PrintDetailsPublic%29&actionid=1

0 · Reply

NVDAMillionaire Nov. 18 at 12:00 PM

$SNOA Brilliant piece that captures SNOA's situation perfectly. So if you want to update your understanding of SNOA or get to know SNOA better, this is essential reading. https://beyondspx.com/quote/SNOA/analysis/sonoma-pharmaceuticals-hocl-s-ascendance-in-dermatology-and-beyond-nasdaq-snoa

0 · Reply

Love_To_Learn Nov. 12 at 9:36 PM

$SNOA need u soon

0 · Reply

Market Cap	4.10M
Revenue (ttm)	14.29M
Net Income (ttm)	-3.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-24.21%
Debt to Equity Ratio	0.00

Volume	9,400
Avg Vol	23,698
Day's Range	N/A - N/A
Shares Out	1.73M
Stochastic %K	66%
Beta	1.76
Analysts	Strong Sell
Price Target	$14.80